pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,723 catalysts · 5,720 phase readout · 2,350 8k filing · 258 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 161 catalysts2026-08-07: 2 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 6 catalysts2026-08-11: 4 catalysts2026-08-12: 8 catalysts2026-08-13: 6 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 5 catalysts2026-10-28: 6 catalysts2026-10-29: 13 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: recall×type: phase readout×clear all
type
  • phase readout5,720
  • 8k filing2,350
  • earnings258
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07434349: Exercise Timing and Postprandial Glucose Responses

Sponsor: Technical University of Munich. Phase: NA. Conditions: Exercise Timing, Postprandial Glucose

full page →ctgov ↗
›RECRUITINGphase readoutNCT07531849: Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas

Sponsor: University of Paris 13. Phase: NA. Conditions: Self-Efficacy, Food Choices, Understanding of Front-of-pack Labeling

full page →ctgov ↗
›COMPLETEDphase readoutNCT07335549: Istmin Levels in Laparoscopik Sleeve Gastrectomy

Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Obesity & Overweight, Sleeve Gastrectomy, Adipokines

full page →ctgov ↗
›RECRUITINGphase readoutNCT06203938: Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Sponsor: Francisco Gonzalez-Lima, PhD. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371338: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Sponsor: Innopeutics Corporation. Phase: PHASE1. Conditions: Parkinson Disease, Parkinson's Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07358338: Application of Device-based Training to Improve Postural Control in Older Adults With CCI

Sponsor: Litvina Lyubov Dmitrievna. Phase: NA. Conditions: Cerebrovascular Disorders, Gait Disorders, Neurologic, Accidental Fall, Aged, Postural Balance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06692738: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06495658: Impact of Prebiotics in Ulcerative Colitis

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Crohn Disease, Ulcerative Colitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05085548: ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Sponsor: ProDa BioTech, LLC. Phase: PHASE1. Conditions: Advanced Pancreatic Cancer, Solid Tumor Malignancies

full page →ctgov ↗
›COMPLETEDphase readoutNCT04630626: Post-Approval Study Protocol for the Simplify Cervical Artificial Disc

Sponsor: NuVasive. Phase: NA. Conditions: Cervical Degenerative Disc Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06002126: Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion, HIV Infections

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07662226: Taste Acceptance and Effectiveness of Hyaluronic Acid and Chlorhexidine Mouthwashes in Children With Gingivitis

Sponsor: Cairo University. Phase: PHASE1. Conditions: Plaque Induced Gingival Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07706348: Intraperitoneal Irrigation of Ondansteron in Combination With Lidocaine in Acute Postoperative Pain

Sponsor: Assiut University. Phase: PHASE1. Conditions: Acue Postoperative Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06866548: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Shanghai Changzheng Hospital. Phase: EARLY_PHASE1. Conditions: mCRPC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07732855: Treatment of Ocular Surface Inflammations

Sponsor: Semmelweis University. Phase: . Conditions: Ocular Surface Allergy, Conjunctivitis, Allergic, Blepharoconjunctivitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04237155: French Source-monitoring Task

Sponsor: Hôpital le Vinatier. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07595926: Height Measurement Procedures Influence the Risk of Ventilator-induced Lung Injury in ARDS

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Acute Respiratory Distress Syndrome, Ventilator-Induced Lung Injury, Tidal Volume, Predicted Body Weight, Height

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04327778: Automate Music Therapy for the Management of Behavioral Disorders in Nursing Homes

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Alzheimer Disease, Major Neurocognitive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07380178: The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis

Sponsor: Universitas Sebelas Maret. Phase: NA. Conditions: Rhinitis, Allergic, Perennial

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07587385: A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Insomnia Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06260943: Targeted Navigation in Hepatocellular Carcinoma (HCC)

Sponsor: University of Miami. Phase: NA. Conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatobiliary Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04969835: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Sponsor: Avacta Life Sciences Ltd. Phase: PHASE1. Conditions: Salivary Gland Tumor, Urothelial Carcinoma, Ovarian Carcinoma, Breast Cancer, Soft Tissue Sarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07043335: Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis

Sponsor: Haydarpasa Numune Training and Research Hospital. Phase: NA. Conditions: Lateral Epicondylitis, Tennis Elbow

full page →ctgov ↗
›RECRUITINGphase readoutNCT02693535: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Sponsor: American Society of Clinical Oncology. Phase: PHASE2. Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07507825: Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Sponsor: First People's Hospital of Hangzhou. Phase: PHASE2. Conditions: Acute Myeloid Leukemia (AML)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07416825: Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Esophageal Cancer, Esophageal Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06647576: Exploring Neurosphere's Remote Monitoring and Virtual Clinic Features in Improve Quality of Life and Reduce Costs

Sponsor: Mahesh Pattabiraman. Phase: . Conditions: Chronic Neuropathic Pain, Chronic Pain Management, Spinal Cord Stimulation (SCS), Pain Modulation, Failed Back Surgery Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT03953976: INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07674576: Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy

Sponsor: CMC Ambroise Paré. Phase: PHASE3. Conditions: Knee Arthroscopy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07469176: Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

Sponsor: Northwestern University. Phase: NA. Conditions: Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07234357: Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia

Sponsor: National Cancer Centre, Singapore. Phase: NA. Conditions: Mild Cognitive Impairment, Mild Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05933057: Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

Sponsor: Italfarmaco. Phase: PHASE3. Conditions: Duchenne Muscular Dystrophy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03172975: Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

Sponsor: Baylor College of Medicine. Phase: PHASE2. Conditions: Hookworm Infections

full page →ctgov ↗
›COMPLETEDphase readoutNCT07114575: Gait Characteristics at Different Speeds in Individuals With Stroke

Sponsor: Ankara Yildirim Beyazıt University. Phase: . Conditions: Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT01223157: Saliva and Plasma Endocannabinoids Concentrations According to Feeding Status and Body Mass Index

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06534957: Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy

Sponsor: Medicos e Investigadores en la Lucha contra el Cancer de Mama. Phase: NA. Conditions: Breast Cancer, Stress

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04792801: PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC

Sponsor: University Hospital, Lille. Phase: . Conditions: Hepatocellular Carcinoma, Liver Transplant

full page →ctgov ↗
›TERMINATEDphase readoutNCT04748419: Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab

Sponsor: University of Nebraska. Phase: PHASE1. Conditions: Lung Cancer, Carcinoma, Non-Small Cell Lung

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07746219: The Clinical Research of Traditional Chinese Medicine Formula

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Phase: PHASE4. Conditions: Urologic Injuries, Kidney Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05126719: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma

Sponsor: Shanghai Miracogen Inc.. Phase: PHASE2. Conditions: Recurrent or Metastatic Nasopharyngeal Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07681219: LRRK2 (Leucine-Rich Repeat Kinase 2) Parkinson's Disease Fingerprint

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Parkinsons Disease (PD), LRRK2

full page →ctgov ↗
›RECRUITINGphase readoutNCT03767530: Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction

Sponsor: Universidad Autonoma de Nuevo Leon. Phase: NA. Conditions: Meibomian Gland Dysfunction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06336928: A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Sponsor: University of Southern California. Phase: . Conditions: Breast Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06255028: A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Sponsor: Century Therapeutics, Inc.. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, Lupus Nephritis, Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07261267: Music Therapy's Effect on Cancer Patients Undergoing Radiotherapy

Sponsor: Kocaeli University. Phase: NA. Conditions: Cancer, Radiotherapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07138365: Clinical and Biochemical Effects Of Cryotherapy Protocols On Mandibular Premolars With Symptomatic Apical Periodontitis

Sponsor: Ain Shams University. Phase: NA. Conditions: Post Operative Pain, Inflammation

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06598865: Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes.

Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète. Phase: NA. Conditions: Diabetes, Type 2, Non-Insulin Dependent, Poorly Controlled Diabetes Mellitus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07322107: Prefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults

Sponsor: Pusan National University Yangsan Hospital. Phase: . Conditions: Stroke, Healthy Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06637371: A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Sponsor: Amgen. Phase: PHASE1. Conditions: Asthma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397871: Salivary Flow, pH, and Buffering Capacity in Fixed and Clear Aligner Orthodontic Treatment

Sponsor: Riyadh Elm University. Phase: NA. Conditions: Orthodontic Treatment, Saliva

full page →ctgov ↗
← prev
page 113 of 115
next →